Literature DB >> 8803778

Marked increase of methylumbelliferyl-tetra-N-acetylchitotetraoside hydrolase activity in plasma from Gaucher disease patients.

W R den Tandt1, F van Hoof.   

Abstract

Methylumbelliferyl-tetra-N-acetylchitotetraoside hydrolase activity was increased 53- to 484-fold in plasma from Gaucher disease patients and no activator could be found. High activity was also measured in other lysosomal storage diseases including Krabbe disease, Wolman disease, GM1-gangliosidosis and to a lesser extent Niemann-Pick disease type B, but the activities were lower than the lowest values in Gaucher patients. Kinetic properties of the high activity in Gaucher plasma were similar to those of controls. It is not known whether the increased activity represents intrinsic enzyme activity or increased enzyme concentration. It is possible that this enzyme may help in the detection of Gaucher disease or in the assessment of enzyme therapy with beta-D-glucosidase (Ceredase).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8803778     DOI: 10.1007/bf01799265

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  19 in total

1.  METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

Authors:  R O BRADY; J N KANFER; D SHAPIRO
Journal:  Biochem Biophys Res Commun       Date:  1965-01-18       Impact factor: 3.575

2.  Characteristics of hexosaminidase A in homogenates of white blood cells using methylumbelliferyl-N-acetyl-beta-D-glucosaminide-6-sulphate as substrate.

Authors:  W R Den Tandt; S Scharpe
Journal:  Clin Chim Acta       Date:  1991-07-15       Impact factor: 3.786

3.  Determination of serum acid phosphatase in Gaucher's disease using 4-methylumbelliferyl phosphate.

Authors:  J P Chambers; L Aquino; R H Glew; R E Lee; L R McCafferty
Journal:  Clin Chim Acta       Date:  1977-10-01       Impact factor: 3.786

4.  Chitinase in goat serum. Preliminary purification and characterization.

Authors:  G Lundblad; B Hederstedt; J Lind; M Steby
Journal:  Eur J Biochem       Date:  1974-07-15

5.  Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.

Authors:  N W Barton; R O Brady; J M Dambrosia; A M Di Bisceglie; S H Doppelt; S C Hill; H J Mankin; G J Murray; R I Parker; C E Argoff
Journal:  N Engl J Med       Date:  1991-05-23       Impact factor: 91.245

6.  Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages.

Authors:  R G Boot; G H Renkema; A Strijland; A J van Zonneveld; J M Aerts
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

7.  Partial purification and further characterization of the novel endoglucosaminidase from human serum that hydrolyses 4-methylumbelliferyl-N-acetyl-beta-D-chitotetraoside (MU-TACT hydrolase).

Authors:  B Overdijk; G J Van Steijn; W R Den Tandt
Journal:  Int J Biochem       Date:  1994-12

8.  Elevated serum and spleen angiotensin converting enzyme and serum lysozyme in Gaucher's disease.

Authors:  E Silverstein; J Friedland
Journal:  Clin Chim Acta       Date:  1977-01-03       Impact factor: 3.786

9.  Human serum contains a chitinase: identification of an enzyme, formerly described as 4-methylumbelliferyl-tetra-N-acetylchitotetraoside hydrolase (MU-TACT hydrolase).

Authors:  B Overdijk; G J Van Steijn
Journal:  Glycobiology       Date:  1994-12       Impact factor: 4.313

10.  Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.

Authors:  C E Hollak; S van Weely; M H van Oers; J M Aerts
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more
  5 in total

1.  Chitotriosidase as a marker of disease activity in sarcoidosis.

Authors:  Jürgen Brunner; Sabine Scholl-Bürgi; Martina Prelog; Lothar-Bernd Zimmerhackl
Journal:  Rheumatol Int       Date:  2007-01-25       Impact factor: 2.631

2.  Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease.

Authors:  J Brinkman; F A Wijburg; C E Hollak; J E Groener; M Verhoek; S Scheij; J Aten; R G Boot; J M Aerts
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with alglucerase.

Authors:  E Young; C Chatterton; A Vellodi; B Winchester
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

4.  Chitotriosidase as a marker of disease activity in sarcoidosis.

Authors:  Jürgen Brunner; Sabine Scholl-Bürgi; Lothar-Bernd Zimmerhackl
Journal:  Rheumatol Int       Date:  2007-05-30       Impact factor: 2.631

5.  Chitotriosidase activity in juvenile idiopathic arthritis.

Authors:  Jürgen K H Brunner; Sabine Scholl-Bürgi; David Hössinger; Petra Wondrak; Martina Prelog; Lothar-Bernd Zimmerhackl
Journal:  Rheumatol Int       Date:  2008-03-07       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.